Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOL-005 Safety and Hair Growth in Healthy Volunteers
NCT02793557Phase 2Completed
- Sponsor
- Follicum
- Start
- Jan 2016
- Primary completion
- Mar 2017
- Modality
- Recombinant Proteins and Enzymes, Modified Peptides, Native Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Follicopeptide in alopecia (5 arms), sponsored by Follicum. Primary endpoint: Number and severity of adverse events at 3 months. Started Jan 2016; status: completed.
02
Drugs
Follicopeptide
03
Conditions
alopecia
Beyond the preview
Go deeper on NCT02793557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02793557.